FDA Approves Outlook Therapeutics' Lytenava as First Ophthalmic Bevacizumab for Wet AMD

The FDA has approved Outlook Therapeutics' Lytenava (bevacizumab-vikg) for the treatment of wet age-related macular degeneration (AMD), making it the first FDA-approved ophthalmic formulation of bevacizumab in the United States. According to Outlook, the approval provides retina specialists with an ophthalmic bevacizumab specifically developed for intravitreal use, rather than relying on repackaged formulations originally intended for intravenous administration.

A Proposed Medicare Policy Would Tie Our Hands in the Fight Against Glaucoma

Chuck Williamson Jr

Glaucoma Today

As an ophthalmic practice administrator, I see every day what it takes to deliver the interventional glaucoma care necessary to preserve sight. It is not a simple cookie-cutter approach. A proposed Medicare policy would make it harder still, replacing physician judgment with a rigid, one-size-fits-all sequence that ignores how differently this disease behaves from patient to patient. What the LCDs Would Restrict Five Medicare Administrative Contractors (MACs) have similar Local Coverage Determinations (LCDs) in the proposal stage and available for comment through July 4. At issue is coverage of the intracameral travoprost implant (iDose TR, Glaukos). If the LCDs become finalized, Medicare would not cover the procedural pharmaceutical unless patients first fail both a trial of selective laser trabeculoplasty (SLT) and two topical medications. The LCD would also bar physicians from placing the implant during a MIGS procedure, whether that MIGS procedure is performed alone or in combination with cataract surgery. If finalized, the LCDs would take decision-making out of the hands of physicians and replace individualized judgment with a fixed treatment sequence applied to every patient. One Treatment Pathway Does Not Fit Every Patient Glaucoma is a heterogeneous disease. It presents and progresses differently in each patient, and physicians need a full range of options to treat each case individually.

Featured Podcasts

Ophthalmology off the Grid

Open. Outspoken. It's Ophthalmology off the Grid—an honest look at controversial topics in the field.

View Feed

New Retina Radio

New Retina Radio is a place to hear stories about retina that are told nowhere else.

View Feed

Eyewire News: The Podcast

Get the latest information and breaking news in the ophthalmic field.

View Feed

Next-Generation FSYX Goggles Approved for Glaucoma

Eyetube

The FDA approves wireless pressure-modulating goggles for at-home glaucoma treatment; Bausch + Lomb launches a new PreserVision AREDS eye vitamin formation; and an Executive Strategic Advisor discusses the regulation environment for communication in eye care. Learn more about your ad choices. Visit megaphone.fm/adchoices

Eyewire News

07.24.2026

FDA Approves Outlook Therapeutics' Lytenava as First Ophthalmic Bevacizumab for Wet AMD

07.27.2026

Aravind Eye Care System, Alcon Launch Global Vitreoretinal Surgery Training Center in India

07.27.2026

Glaukos Completes Enrollment in US Pivotal Study of Preserflo MicroShunt for POAG

07.24.2026

Topcon Receives CE Mark for GAIA Ultra-Widefield Retinal Imaging System

07.24.2026

Théa, Unither Pharmaceuticals Partner on Dedicated Ophthalmic Manufacturing Facility in France

EyewireTV

07.22.2026

The Latest EyewireTV

PRIMA Retinal Implant Launched in Europe Following CE Mark

B+L Launches EyeGility Inserter Preloaded IOL Delivery System in US

Update on Clinical Development Milestone

Stocks

Cataract

MIGS and Cataract Surgery

Seeing More of the Cornea

Interventional Glaucoma: A Collaborative Care Model for the Future of Glaucoma Management

A History of TASS Prevention

Elara 900: Reinventing the Clinical Workhorse

Visual Disturbances and Satisfaction After Multifocal IOL Implantation

07.24.2026

Théa, Unither Pharmaceuticals Partner on Dedicated Ophthalmic Manufacturing Facility in France

07.21.2026

Pediatric Cataract Surgery May Alter Coordination of Ocular Growth, International Study Finds

07.21.2026

Fundamental XR, Orbis Report Early Success of VR Ophthalmic Training Program Across Africa

07.17.2026

Moorfields and University College London Launch CADMUS Anterior Segment Imaging Dataset

Refractive

A History of TASS Prevention

MIGS and Cataract Surgery

Genetically Predisposed to Capsular Bag Instability

Conjunctivochalasis and Hyaluronic Acid in the Dry Eye Space

Addressing Inflammatory Dry Eye

MIGS Device Selection in Practice

07.23.2026

iVeena Reports FDA Alignment on Phase 2 Development Plan for Pediatric Myopia Candidate IVMED-85

07.21.2026

Fundamental XR, Orbis Report Early Success of VR Ophthalmic Training Program Across Africa

07.17.2026

Moorfields and University College London Launch CADMUS Anterior Segment Imaging Dataset

07.17.2026

iVeena Reports Favorable Phase 1 Safety Data for Investigational Pediatric Myopia Therapy IVMED-85

Stay Updated

Follow Eyewire News

Retina

Spotlight on UNITY® VCS Dynamic Stiffener 27+

Rising Stars in Retina: Fares Antaki, MDCM

Peripheral Firestorm: The Ischemic Retina

Spotlight on UNITY® VCS: Experience Extraordinary

Macula-Off Retinal-Choroidal Detachment

Petaloid Self-Coiling ILM Covering Technique for Macular Hole Repair

07.27.2026

Aravind Eye Care System, Alcon Launch Global Vitreoretinal Surgery Training Center in India

07.24.2026

Topcon Receives CE Mark for GAIA Ultra-Widefield Retinal Imaging System

07.24.2026

Study: Mediterranean Diet Linked to Slower AMD Progression Across Disease Stages

07.24.2026

Tirzepatide Associated With Lower Risk of Diabetic Retinopathy Progression and Treatment

Glaucoma

A Proposed Medicare Policy Would Tie Our Hands in the Fight Against Glaucoma

iTrack Advance: Collector Channel Intubation

Three Real-World Scenarios in Which a Minimally Invasive Approach Prevailed

Viscodilation and Goniotomy With iTrack

Cataract Surgery and Hydrus Implantation

GATT in a Patient With Steroid-Response Glaucoma and Ocular Surface Medicamentosa

07.27.2026

Glaukos Completes Enrollment in US Pivotal Study of Preserflo MicroShunt for POAG

07.24.2026

Théa, Unither Pharmaceuticals Partner on Dedicated Ophthalmic Manufacturing Facility in France

07.21.2026

Fundamental XR, Orbis Report Early Success of VR Ophthalmic Training Program Across Africa

07.17.2026

Glaucoma UK Launches Nationwide Patient Survey Targeting 10,000 Responses

Spotlight on UNITY^® VCS Dynamic Stiffener 27+

Spotlight on UNITY^® VCS: Experience Extraordinary